Systemic effects reported or plausibly linked to elevated growth hormone and IGF-1 include water retention, tingling or numbness (paresthesia), joint discomfort, headache, flushing, and transient changes in glucose handling
The altered pharmacokinetics in advanced liver disease and the potential for medication-related complications require careful consideration of risks and benefits
The PEG moiety also reduces immunogenicity and improves aqueous solubility, which are practical advantages in cell culture systems
GLP-1, generally short for GLP1-RA, which is a class or type of diabetes medication, stands for Glucagon- Like Peptide 1 Receptor Agonist
"Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes (SUSTAIN 5)"